Literature DB >> 7576421

Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II.

G T Carter1, R T Abresch, W M Fowler, E R Johnson, D D Kilmer, C M McDonald.   

Abstract

Data were collected prospectively for an impairment and disability profile for 86 hereditary motor and sensory neuropathy, types I and II (HMSN) subjects over a 10-yr period. Our data confirm that HMSN is a slowly progressive disorder that has a very heterogeneous phenotypical expression. The disorder was characterized primarily by diffuse muscle weakness with prominent distal atrophy. The mean manual muscle test (MMT) strength grade for all muscle groups combined was 3.9 +/- 0.7 MMT units. There was a slowly progressive decline in strength, only -0.15 MMT units per decade. Distal muscle groups were weaker than proximal muscles, and the decline in strength of the ankle muscles was greater than for the proximal muscles. There was no side dominance. Anthropometric data revealed that distal atrophy may be masked by subcutaneous fat in female subjects. On average, HMSN subjects produced 20-40% less force than normal controls, using quantitative isometric and isokinetic strength measures, even when MMT scores were normal. Pulmonary and cardiac abnormalities were uncommon, as were spine deformity and joint contractures. Only 1 individual had severe restrictive lung disease, and 12 (14%) had a history of significant respiratory complications with no age or disease duration effect. As with the other neuromuscular diseases, maximum expiratory pressure was more affected than forced vital capacity. Fourteen individuals (30%) had abnormal electrocardiograms, and six (7%) had a history of significant cardiovascular complications with no age or disease duration effect. Kyphosis was the major spine deformity. Cardiopulmonary responses to exercise testing were markedly abnormal, showing reduced aerobic capacity. Functional evaluations and timed motor performance tests showed only mild disability in most individuals. With timed motor performance testing muscle weakness translated to impaired motor performance skills. Overall, mean scores on intellectual function and neuropsychologic profiles were normal.

Entities:  

Mesh:

Year:  1995        PMID: 7576421     DOI: 10.1097/00002060-199509001-00008

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  16 in total

1.  Depression and Charcot-Marie-Tooth disease.

Authors:  P Vinci; P Gargiulo; G B Colazza
Journal:  Neurol Sci       Date:  2007-10       Impact factor: 3.307

Review 2.  Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases.

Authors:  Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

Review 3.  Prevention and management of limb contractures in neuromuscular diseases.

Authors:  Andrew J Skalsky; Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

4.  Long-term results of reconstruction for treatment of a flexible cavovarus foot in Charcot-Marie-Tooth disease.

Authors:  Christina M Ward; Lori A Dolan; D Lee Bennett; Jose A Morcuende; Reginald R Cooper
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

5.  Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease.

Authors:  Gita M Ramdharry; Brian L Day; Mary M Reilly; Jonathan F Marsden
Journal:  Muscle Nerve       Date:  2009-07       Impact factor: 3.217

6.  Charcot-Marie-Tooth disease.

Authors:  Gregory T Carter; Michael D Weiss; Jay J Han; Phillip F Chance; John D England
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

7.  Pain in youths with neuromuscular disease.

Authors:  Joyce M Engel; Deborah Kartin; Gregory T Carter; Mark P Jensen; Kenneth M Jaffe
Journal:  Am J Hosp Palliat Care       Date:  2009 Oct-Nov       Impact factor: 2.500

8.  A study of physical activity comparing people with Charcot-Marie-Tooth disease to normal control subjects.

Authors:  Gita M Ramdharry; Alexander J Pollard; Robert Grant; Elizabeth L Dewar; Matilde Laurá; Sarah A Moore; Kate Hallsworth; Thomas Ploetz; Michael I Trenell; Mary M Reilly
Journal:  Disabil Rehabil       Date:  2016-08-16       Impact factor: 3.033

9.  Genetic variants in GPR126 are associated with adolescent idiopathic scoliosis.

Authors:  Ikuyo Kou; Yohei Takahashi; Todd A Johnson; Atsushi Takahashi; Long Guo; Jin Dai; Xusheng Qiu; Swarkar Sharma; Aki Takimoto; Yoji Ogura; Hua Jiang; Huang Yan; Katsuki Kono; Noriaki Kawakami; Koki Uno; Manabu Ito; Shohei Minami; Haruhisa Yanagida; Hiroshi Taneichi; Naoya Hosono; Taichi Tsuji; Teppei Suzuki; Hideki Sudo; Toshiaki Kotani; Ikuho Yonezawa; Douglas Londono; Derek Gordon; John A Herring; Kota Watanabe; Kazuhiro Chiba; Naoyuki Kamatani; Qing Jiang; Yuji Hiraki; Michiaki Kubo; Yoshiaki Toyama; Tatsuhiko Tsunoda; Carol A Wise; Yong Qiu; Chisa Shukunami; Morio Matsumoto; Shiro Ikegawa
Journal:  Nat Genet       Date:  2013-05-12       Impact factor: 38.330

10.  Gpr126/Adgrg6 deletion in cartilage models idiopathic scoliosis and pectus excavatum in mice.

Authors:  Courtney M Karner; Fanxin Long; Lilianna Solnica-Krezel; Kelly R Monk; Ryan S Gray
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.